The management of menopause in women with a history of endometriosis: a systematic review
Open accessThe DOI matches its Crossref record; 105 of the 108 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Endometriosis is typically regarded as a premenopausal disease, resolving after natural or iatrogenic menopause due to declining oestrogen levels. Nonetheless, case reports over the years have highlighted the incidence of recurrent postmenopausal endometriosis. It is now clear that both recurrence and malignant transformation of endometriotic foci can occur in the postmenopausal period. Postmenopausal women are commonly treated with hormone replacement therapy (HRT) to treat climacteric symptoms and prevent bone loss; however, HRT may reactivate endometriosis and stimulate malignant transformation in women with a history of endometriosis. Given the uncertain risks of initiating HRT, it is difficult to determine the best menopausal management for this group of women. OBJECTIVE AND RATIONAL: The aim of this study was to systematically review the existing literature on management of menopausal symptoms in women with a history of endometriosis. We also aimed to evaluate the published literature on the risks associated with HRT in these women, and details regarding optimal formulations and timing (i.e. initiation and duration) of HRT. SEARCH METHODS: Four electronic databases (MEDLINE via OVID, Embase via OVID, PsycINFO via OVID and CINAHL via EbscoHost) were searched from database inception until June 2016, using a combination of relevant controlled vocabulary terms and free-text terms related to 'menopause' and 'endometriosis'. Inclusion criteria were: menopausal women with a history of endometriosis and menopausal treatment including HRT or other preparations. Case reports/series, observational studies and clinical trials were included. Narrative review articles, organizational guidelines and conference abstracts were excluded, as were studies that did not report on any form of menopausal management. Articles were assessed for risk of bias and quality using GRADE criteria. OUTCOMES: We present a synthesis of the existing case reports of endometriosis recurrence or malignant transformation in women undergoing treatment for menopausal symptoms. We highlight common presenting symptoms, potential risk factors and outcomes amongst the studies. Sparse high-quality evidence was identified, with few observational studies and only two randomized controlled trials. Given this paucity of data, no definitive conclusions can be drawn concerning risk. WIDER IMPLICATIONS: Due to the lack of high-quality studies, it remains unclear how to advise women with a history of endometriosis regarding the management of menopausal symptoms. The absolute risk of disease recurrence and malignant transformation cannot be quantified, and the impact of HRT use on these outcomes is not known. Multicentre randomized trials or large observational studies are urgently needed to inform clinicians and patients alike.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Notably, seven of these 14 reported cases had extensive or severe endometriosis.”
From HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey (2023) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the time lag (4 years) in our case between hysterectomy and the presentation with endometriosis recurrence was similar to the previously reported time (median 7.1 years) in the 14 case reports [8].”
From HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a systematic review, Gemmell et al. found that 13 out of the 14 reported cases of endometriosis recurrence after surgical menopause were receiving EO-HRT, while only one was on combined HRT [8].”
From HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With regard to timing of HRT after pelvic clearance with complete excision of endometriosis, limited available short-term data suggest that immediate start of HRT seems to be safe with no increased risk of endometriosis recurrence [8].”
From HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the systematic review reported that HRT was also associated with a risk of malignant transformation [8].”
From HRT in Women Undergoing Pelvic Clearance for Endometriosis—A Case Report and a National Survey (2023) · cites this paper as [8]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 3×
“In response to concerns regarding an increased risk of breast cancer raised by the Women’s Health Initiative (Rossouw et al., 2002) and the Million Women Study (Collaborators, 2003), HRT usage substantially decreased (Hersh et al.”
BackgroundGRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094 · cited 3×
“Quality of included studies was assessed independently by two reviewers (L.G., K.W.) using the GRADE criteria (Guyatt et al., 2011).”
BackgroundMethodInfluentialBreast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211 · cited 7×
“consensus statements and recommendations acknowledge this deficit, but continue to emphasize the benefits of HRT over the undefined risks for severely symptomatic women (Al Kadri et al., 2009; Johnson and Hummelshoj, 2013; Dunselman et al., 2014).”
BackgroundInfluentialSelf-citationEndometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940 · cited 2×
“states that endometrial cells travel backwards through the fallopian tubes during menses to reach the peritoneal cavity, has gathered the most robust support (Vercellini et al., 2014).”
BackgroundBulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741 · cited 2×
“, 2003) and cardiovascular health (Rossouw et al., 2007), particularly for younger patients, against the potential risks of recurrence or malignancy.”
BackgroundManson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650 · cited 1×
“HRT has been crucial for achieving symptom relief and improving the quality of life of millions of menopausal women, although these successes have been accompanied by safety concerns regarding specific preparations and dosages (Manson et al., 2013).”
BackgroundPathogenesis and pathophysiology of endometriosis
Burney, R. O., & Giudice, L. C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.029 · Cited by 1,590 · cited 1×
“Oestrogen dependence, progesterone resistance, inflammation and genetic predisposition represent some of the pathophysiological hallmarks of this disease (Burney and Giudice, 2012).”
BackgroundCauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,221 · cited 2×
“For these women, clinicians must balance the benefits to bone (Cauley et al., 2003) and cardiovascular health (Rossouw et al.”
Background
Research works printed but not linked: 3
- Arumugam, 1998, Endometriosis and estrogen replacement therapy, Med Sci Res, 26, 333
- Chung, 2008, Postmenopausal malignant transformation of extragenital endometriosis. A case report, Gynecol Obstet Fertil, 36, 51
- Review Manager (RevMan) [Computer program]. Version 5.3, 2014
Cited by
ESHRE guideline: endometriosis
Becker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac009 · Cited by 1,712
“Clinicians may consider combined menopausal hormone therapy for the treatment of postmenopausal symptoms in women (both after natural and surgical menopause) with a history of endometriosis (Matorras et al. , 2002; Gemmell et al. , 2017).”
Self-citationZondervan, K. T., Becker, C. M., Koga, K., Missmer, S. A., Taylor, R. N., & Viganò, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0008-5 · Cited by 1,257
Self-citationPathophysiology, diagnosis, and management of endometriosis
Horne, A. W., & Missmer, S. A. (2022) · BMJ · doi:10.1136/bmj-2022-070750 · Cited by 661
Clinical Management of Endometriosis
Falcone, T., & Flyckt, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002469 · Cited by 569
As-Sanie, S., Mackenzie, S. C., Morrison, L., Schrepf, A., Zondervan, K. T., Horne, A. W., & Missmer, S. A. (2025) · JAMA · doi:10.1001/jama.2025.2975 · Cited by 249
Self-citation
Metadata
- Authors
- Gemmell, L. C., Webster, K. E., Kirtley, S., Vincent, K., Zondervan, K. T., & Becker, C. M.
- Affiliations
- Case Western Reserve University (US)
- John Radcliffe Hospital (GB)
- Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, Windmill Road, Oxford OX3 7LD, UK
- Centre for Human Genetics (GB)
- Corresponding author
- Becker, C.M.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-11
- Volume
- 23
- Issue
- 4
- Pages
- 481-500
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- PMC
- PMC5850813
- OpenAlex
- W2613425805
- Cited by
- 154
- References
- 108
- Citations by year
- 2026: 23 · 2025: 19 · 2024: 23 · 2023: 14 · 2022: 14 · 2021: 16 · 2020: 14 · 2019: 15 · 2018: 13 · 2017: 3
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Human Reproduction Update (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DSpace repository (University of Tartu) (submittedVersion, other-oa)
- Explore Bristol Research (submittedVersion)
- Funders
- Academy of Medical Sciences (AMS-SGCL8-Vincent)
- European Commission (692065, HORIZON2020)
- Bayer HealthCare
- Medical Research Council (MR/K011480/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- endometriosis, menopause, hormone replacement therapy, endometriosis-associated cancer, malignant transformation, menopausal symptoms, climacteric, estrogen withdrawal, bone loss prevention, patient counseling, shared decision-making
- MeSH terms
- Endometriosis, Estrogens, Female, Humans, Menopause, Neoplasm Recurrence, Local, Risk Factors, Estrogen Replacement Therapy, Randomized Controlled Trials as Topic, Endometrial Neoplasms, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The management of menopause in women with a history of endometriosis: a systematic review. https://app.cochat.ai/papers/10.1093/humupd/dmx011
- The paper
- Gemmell, L. C., Webster, K. E., Kirtley, S., Vincent, K., Zondervan, K. T., & Becker, C. M. (2017). The management of menopause in women with a history of endometriosis: a systematic review. Human Reproduction Update. https://doi.org/10.1093/humupd/dmx011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

